What condition does Ajovy (fremanezumab) treat?
Ajovy is used to prevent migraine in adults. It can be prescribed for patients who have episodic migraine (migraine with fewer headache days) or chronic migraine (migraine with more headache days).
How is Ajovy taken—monthly or every 3 months?
Ajovy is given by injection. It comes with dosing options of either:
- 225 mg once per month, or
- 675 mg once every 3 months
What’s Ajovy meant to do (prevention vs. stopping an attack)?
Ajovy is a preventive treatment. It helps reduce how often migraine attacks happen over time, rather than treating a migraine attack once it has started.
Who might be a candidate for Ajovy?
Ajovy is typically considered for people who need ongoing migraine prevention, including those who:
- have frequent migraines, or
- still have migraines despite other preventive options
What’s Ajovy’s approach in the body?
Ajovy (fremanezumab) targets CGRP (calcitonin gene-related peptide), a key molecule involved in migraine biology. By blocking CGRP signaling, it helps lower the likelihood of migraine attacks.
What happens if it stops working or you miss doses?
If Ajovy’s effect wears off or you miss scheduled injections, migraine frequency may increase again. Patients usually restart the dosing schedule as directed by their clinician to regain preventive benefit.